Kathryn O'Driscoll was Appointed as Chief People Officer at Zymeworks

Date of management change: December 09, 2019 

What Happened?

Vancouver, BC-based Zymeworks Appointed Kathryn O\'Driscoll as Chief People Officer

 

About the Company

Zymeworks (NASDAQ:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks` suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. Zymeworks` lead clinical candidate, zanidatamab, is a novel Azymetric™ HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. Zymeworks` second product candidate, Zanidatamab Zovodotin (ZW49), is a bispecific antibody-drug conjugate currently in Phase 1 clinical development and combines the unique design and antibody framework of zanidatamab with Zymeworks` proprietary ZymeLink™ linker-cytotoxin. Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged through strategic partnerships with nine biopharmaceutical companies.

 

About the Person

Kathryn O'Driscoll is Chief People Officer at Zymeworks. Previously, Kathryn held various senior HR leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Flores Jennifer, Ledbetter Thomas, Deelstra Jason, Klostermeier Janice, Khong Christon, Homes Paula, Patno Andrea, Phillips Nathan, Souliere Christine, Gulati Amy, Street James

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.